NGL Fine-Chem Ltd (NSE:NGLFINE) Share Price

Company Profile

Business description
NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. It is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health, catering to various companies to custom-manufacture pharmaceuticals. The company's product portfolio comprises animal health APIs such as homidium chloride, nitroxynil, clorsulon, decoquinate, fenbendazole, etc.; human health APIs such as nitazoxanide and atovaquone; drug intermediates and specialty chemicals; and finished dosage forms such as diminazene aceturate granules and homidium chloride tablets. Geographically, the group generates maximum revenue from the Asia-Pacific region, and the rest from India, Europe, the USA, and the rest of the world.
Contact
301, E Square, Subhash Road
Vile Parle (East)
MumbaiMH400057
IND
T: +91 2240842222
https://www.nglfinechem.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2027
Employees
523

Recommended

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.

Malik Ahmed Khan, CFA | 24 April 2026

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Mark Taylor | 24 April 2026

ChatGPT and large language models should be a tailwind for this company.

Simonelle Mody | 24 April 2026

Index	Last price	Change	% Change
All Ordinaries	8,990.80	20.60	0.23%
CAC 40	8,131.77	26.05	-0.32%
DAX 40	24,065.12	63.86	-0.26%
Dow JONES (US)	49,057.09	173.62	-0.35%
FTSE 100	10,320.18	58.90	-0.57%
HKSE	25,925.65	52.42	-0.20%
NASDAQ	24,765.12	71.48	-0.29%
Nikkei 225	60,537.36	821.18	1.38%
NZX 50 Index	12,874.94	9.99	-0.08%
S&P 500	7,154.13	10.95	-0.15%
S&P/ASX 200	8,766.40	17.20	0.20%
SSE Composite Index	4,086.34	6.44	0.16%